133230-55-4

Upstream product

• 133230-54-3 5-Allyl-5-benzyl-2-trifluoromethyl-1,5-dihydro-imidazol-4-one 
• 350-09-4 N-trifluoroacetyl-L-phenylalanine 
• 141408-63-1 N-(trifluoroacetyl)-α-allylphenylalaninamide 
• 133230-43-0 N-(trifluoroacetyl)-L-phenylalanine allyl ester 
• 63-91-2 L-phenylalanine 
• 108888-99-9 3-Phenyl-2-{[1-phenyl-meth-(E)-ylidene]-amino}-propionamide 
• 106-95-6 allyl bromide 

Downstream Products

• 133230-56-5 N-(Boc-Asp(OBn))-α-allylphenylalaninamide 
• 105743-57-5 (S)-2-amino-2-benzyl-4-pentenoic acid 
• 133230-58-7 N-(Boc-Asp(OBn))-α-(3-hydroxy-n-propyl)phenylalaninamide 
• 141408-65-3 N-(Boc-Asp(OBn))-α-benzylprolinamide 

Relevant academic research and scientific papers

DERIVATIVES OF TETRAPEPTIDES AS CCK AGONISTS

Selective and potent Type-A CCK receptor agonists of formula (I):X--Y--Z--Q (I)or a pharmaceutically acceptable salt thereof, wherein,X is selected from STR1 Y is selected from STR2 Z is STR3 and Q is STR4 or pharmaceutically-acceptable

Synthesis of α,α-Disubstituted α-Amino Acid Amides by Phase-Transfer Catalyzed Alkylation

α,α-Disubstituted α-amino acid amides were prepared in 17-88 percent chemical yield by the phase-transfer catalyzed alkylation of N-benzylidene α-H amino acid amides, followed by weak acidic hydrolysis of the Schiff bases.